See also this year's filing and all EDGAR filings for this company.
PDF Report 0001072379_2020_Northwest_Biotherapeutics_INC.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Ambiguous roles for statement | input.sec.calculation_linkbase.expand_agg | {'statement': 'operations', 'valid_roles': {'00200 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - Calc 2': 2, '00200 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS': 15}} |
Graph
Absolute values for 0001072379, Northwest Biotherapeutics INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 3,200,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 281,000 |
| 3 | remainder_Assets | 5,648,000 |
| 4 | LiabilitiesCurrent | 41,194,000 |
| 5 | LiabilitiesNoncurrent | 11,502,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 15,351,573 |
| 9 | ResearchAndDevelopmentExpense | 9,919,189 |
| 10 | remainder_Expenses | 4,016,484 |
| 11 | remainder_Revenues | 2,807,013 |
| 12 | remainder_NetIncome | 7,806,532 |
| 13 | remainder_ComprehensiveNetIncome | 982,731 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 9,129,000 |
| 1 | Liabilities | 52,696,000 |
| 2 | Expenses | 29,287,246 |
| 3 | Revenues | 2,807,013 |
| 4 | StockholdersEquity | -43,567,000 |
| 5 | NetIncome | -18,673,701 |
| 6 | ComprehensiveNetIncome | -18,182,336 |
| 7 | BaseVar | 51,354,261 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -3.66 |
| 9 | EconomicCapitalRatio | 0.483 |
Edgar->Model Mapping
Feature Distribution
Change over Time
